LH-708

N/A

Report date: 2025/12/08 17:52:54
NME

Base Information

Drug NameLH-708
Drug Alias Namecystine stone formation inhibitors (PharmaKrysto)PK-10 (PharmaKrysto)L-cystine bis(N'-methylpiperazide)LH-708L-CDNMP
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCystinuria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRutgers University
China Registration ClassN/A

Develop Information

Active CompaniesPharmaKrysto Ltd
Inactive CompaniesRutgers University
Active IndicationsCystinuria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A